iRadimed Corporation (IRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRMD trades at $90.40 with a market cap of $1.13B and a P/E ratio of 47.84. IRMD moved +1.82% today. Year to date, IRMD is -8.04%; over the trailing twelve months it is +69.64%. Its 52-week range spans $46.86 to $107.90. Analyst consensus is buy with an average price target of $116.00. Rallies surfaces IRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading IRMD stock inside the company?
Recent IRMD insider activity includes Susi Roger E. sold 653, Susi Roger E. sold 1.84K, Susi Roger E. sold 6, Susi Roger E. sold 298, and Susi Roger E. sold 3.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
IRMD Key Metrics
Key financial metrics for IRMD
Metric
Value
Price
$90.40
Market Cap
$1.13B
P/E Ratio
47.84
EPS
$1.86
Dividend Yield
0.20%
52-Week High
$107.90
52-Week Low
$46.86
Volume
13
Avg Volume
0
Revenue (TTM)
$86.28M
Net Income
$23.61M
Gross Margin
76.83%
Recent IRMD Insider Trades
Susi Roger E. sold 653 (~$56.90K) on May 19, 2026.
Susi Roger E. sold 1.84K (~$162.27K) on May 19, 2026.
Susi Roger E. sold 6 (~$531.9) on May 19, 2026.
Susi Roger E. sold 298 (~$25.61K) on May 18, 2026.
Susi Roger E. sold 3.45K (~$301.44K) on May 18, 2026.
Recent IRMD insider activity includes Susi Roger E. sold 653, Susi Roger E. sold 1.84K, Susi Roger E. sold 6, Susi Roger E. sold 298, and Susi Roger E. sold 3.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IRMD?
Yes. Rallies tracks IRMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IRMD. It does not provide personalized investment advice.
